TTNP - Titan Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue21515,0651,671
Cost of Revenue---
Gross Profit21515,0651,671
Operating Expenses
Research Development9,6486,1264,675
Selling General and Administrative5,0694,5963,755
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-14,5024,343-6,759
Income from Continuing Operations
Total Other Income/Expenses Net8141,617-9,032
Earnings Before Interest and Taxes-14,0575,997-15,791
Interest Expense---
Income Before Tax-14,0575,997-15,791
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-14,0575,997-15,791
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-14,0575,997-15,791
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-14,3075,135-11,279